MA
GSK icon

MKT Advisors’s GSK GSK Stock Holding History

MKT Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-5,646
Closed -$211K – 148
2023
Q1 		$211K Buy
+5,646
New +$198K 0.16% 129
2022
Q3 		– Sell
-6,082
Closed -$321K – 131
2022
Q2 		$321K Sell
6,082
-192
-3% -$10.6K 0.25% 84
2022
Q1 		$338K Sell
6,274
-199
-3% -$10.8K 0.26% 82
2021
Q4 		$357K Buy
+6,473
New +$337K 0.28% 78

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

MKT Advisors's GSK Position: Q2 2023 in Review

MKT Advisors sold out of GSK (GSK) in Q2 2023, closing a stake of 5,646 shares — an estimated $211K sold.

MKT Advisors first reported a position in GSK in Q4 2021 and held it in 4 quarters. The position peaked at $357K in Q4 2021. 827 funds tracked by Wall St. Rank hold GSK as of Q2 2023.

  • MKT Advisors reported no remaining GSK position as of Q2 2023 after selling out during the quarter.
  • MKT Advisors sold 5,646 GSK shares in Q2 2023, an estimated $211K.
  • MKT Advisors first reported a position in GSK in Q4 2021 and held it in 4 quarters.
  • MKT Advisors's GSK position peaked at $357K in Q4 2021.
  • 827 funds tracked by Wall St. Rank held GSK as of Q2 2023.

Based on MKT Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.